Literature DB >> 8108669

Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis.

A A Stenger1, P M Houtman, G A Bruyn, H F Eggink, H R Pasma.   

Abstract

Since 1983 there have been several reports on Pneumocystis carinii pneumonia (PCP), complicating low dose methotrexate (MTX) therapy for rheumatoid arthritis (RA). Two additional cases of this opportunistic infection are reported and a review of the literature on the complication is presented. It is concluded that PCP is a serious complication of low dose MTX therapy for RA and should always be ruled out when a patient presents with pulmonary symptoms. Several factors may play a role in the occurrence of this opportunistic infection, but the exact mechanism has not yet been elucidated.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8108669     DOI： 10.3109/03009749409102137

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


  8 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

2.  Pulmonary coinfection by Pneumocystis carinii and Aspegillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate.

Authors:  M Mariñosa; A Soler; X Nogués; J Pedro-Botet
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

Review 3.  [Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review].

Authors:  B Bertisch; C Ruef
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

4.  Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.

Authors:  Shin-Ichiro Ohmura; Yoichiro Homma; Takayuki Masui; Toshiaki Miyamoto
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

5.  Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.

Authors:  J D Greenberg; G Reed; J M Kremer; E Tindall; A Kavanaugh; C Zheng; W Bishai; M C Hochberg
Journal:  Ann Rheum Dis       Date:  2009-04-08       Impact factor: 19.103

Review 6.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

7.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

Review 8.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.